CSIMarket
 
Blue Water Vaccines Inc  (NASDAQ: BWV)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 2
 Employees 11
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -9
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 0

Business Description


Blue Water Biotech Inc is a biotechnology company that focuses on developing innovative solutions for the water industry. They aim to address the global water crisis by creating sustainable and environmentally friendly technologies. The company's products and services include water treatment systems, wastewater management solutions, and water quality monitoring tools. Blue Water Biotech Inc combines cutting-edge scientific research with practical application to provide effective and efficient water treatment solutions. They strive to improve water quality and conserve resources for a better future.


   Company Address: 201 E. Fifth Street Cincinnati 45202 OH
   Company Phone Number: 620-4101   Stock Exchange / Ticker: NASDAQ BWV


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ANVS   -19.19%    
CNSP   -5.27%    
CYDY   -13.04%    
EVFM   -3.75%    
ZYME        3.25% 
ICU   -3.56%    
• View Complete Report
   



Stock Market Announcement

Onconetix's Breakthrough Treatment: A Paradigm Shift in Cancer Care

Published Tue, Dec 19 2023 12:00 PM UTC

Cancer Breakthrough: Onconetix s Innovative Treatment Shows Promising Results, Says CEO Dr. Neil Campbell
CINCINNATI, Dec. 19, 2023 - Onconetix, Inc., a leading biotechnology firm specializing in cancer research and treatment, recently released a breakthrough announcement outlining the remarkable progress they have made in their battle against the deadly disease. In a sh...

Merger and Acquisition

Blue Water Biotech Acquires Proteomedix: Revolutionizing Oncology with Advanced Prostate Cancer Diagnostics; Introducing Onconetix, the Future of Precise Cancer Care

Published Mon, Dec 18 2023 12:00 PM UTC

Transaction strengthens commercial business with addition of diagnostics product and initial focus on prostate cancer
Blue Water Biotech, a leading biotechnology company, has recently announced its acquisition of Proteomedix, a cutting-edge diagnostics company specializing in the development of advanced tests for urological diseases, particularly prostate cancer. This st...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 2
Working Capital Ratio 2.31
Leverage Ratio (MRQ) 0.22
Total Debt to Equity 0.01
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -8.54 $
Revenues (TTM) 0.29 $
Cash Flow (TTM) 1.53 $
Cash 2.65 $
Book Value 6.01 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 58,712
Net Income per Employee (TTM) -790,689
Receivable Turnover Ratio (TTM) 7.41
Inventory Turnover Ratio (TTM) 0.78
Asset Turnover Ratio (TTM) 0.03

Profitability Ratios Current
Gross Margin (MRQ) 25.13 %
Operating Margin (MRQ) -15950.88 %
Net Margin (MRQ) -16748.27 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Blue Water Vaccines Inc's Segments
GB    164.71 % of total Revenue
CH    58.82 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.